Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation.

Friedman TM, Goldgirsh K, Berger SA, Zilberberg J, Filicko-O'Hara J, Flomenberg N, Donato M, Rowley SD, Korngold R. Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vbeta use: a new paradigm for designer allogeneic blood and marrow transplantation. Blood. 2008 Oct 15; 112(8):3517-25.

View in: PubMed